{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T21:44:00Z","timestamp":1745012640382,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011531","name":"University of Alabama","doi-asserted-by":"publisher","award":["P30 DK079337"],"award-info":[{"award-number":["P30 DK079337"]}],"id":[{"id":"10.13039\/100011531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K24DK110427"],"award-info":[{"award-number":["K24DK110427"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2BX004986"],"award-info":[{"award-number":["IK2BX004986"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.xkme.2024.100831","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T01:54:45Z","timestamp":1713923685000},"page":"100831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proneurotensin\/Neuromedin N and Risk of Incident CKD and Other Kidney Outcomes in Community-Living Individuals: The REGARDS Study"],"prefix":"10.1016","volume":"6","author":[{"given":"Alexander L.","family":"Bullen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Fregoso-Leyva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy Leann","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine L.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne E.","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando M.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena E.","family":"Rifkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xkme.2024.100831_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41581-019-0120-0","article-title":"Kidney disease in the Global Burden of Disease Study 2017","volume":"15","author":"Fraser","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"10159","key":"10.1016\/j.xkme.2024.100831_bib2","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.xkme.2024.100831_bib3","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/ijms18081702","article-title":"Novel biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome","volume":"18","author":"Rysz","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.xkme.2024.100831_bib4","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.xkme.2024.100831_bib5","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1016\/S0021-9258(19)43429-7","article-title":"The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami","volume":"248","author":"Carraway","year":"1973","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.xkme.2024.100831_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.peptides.2006.01.021","article-title":"Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation","volume":"27","author":"Ernst","year":"2006","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.xkme.2024.100831_bib7","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/ATVBAHA.116.307847","article-title":"Circulating proneurotensin concentrations and cardiovascular disease events in the community: the Framingham Heart Study","volume":"36","author":"Januzzi","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"10.1016\/j.xkme.2024.100831_bib8","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2012.12998","article-title":"Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality","volume":"308","author":"Melander","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.xkme.2024.100831_bib9","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1210\/jc.2017-02424","article-title":"Proneurotensin predicts cardiovascular disease in an elderly population","volume":"103","author":"Fawad","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.xkme.2024.100831_bib10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/1358863X20957406","article-title":"Pro-neurotensin\/neuromedin N and risk of ischemic stroke: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"25","author":"Nicoli","year":"2020","journal-title":"Vasc Med"},{"issue":"7603","key":"10.1016\/j.xkme.2024.100831_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature17662","article-title":"An obligatory role for neurotensin in high-fat-diet-induced obesity","volume":"533","author":"Li","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.xkme.2024.100831_bib12","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/jc.2017-02751","article-title":"Increased plasma proneurotensin levels identify NAFLD in adults with and without type 2 diabetes","volume":"103","author":"Barchetta","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.xkme.2024.100831_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/nu10040526","article-title":"Neurotensin is a lipid-induced gastrointestinal peptide associated with visceral adipose tissue inflammation in obesity","volume":"10","author":"Barchetta","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.xkme.2024.100831_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0196-9781(82)90012-2","article-title":"Localization of neurotensin binding sites in rat kidney","volume":"3","author":"Quirion","year":"1982","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.xkme.2024.100831_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0167-0115(87)90047-4","article-title":"Renal function during bovine neurotensin infusion in man","volume":"18","author":"Unwin","year":"1987","journal-title":"Regul Pept"},{"issue":"2","key":"10.1016\/j.xkme.2024.100831_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00000441-200202000-00006","article-title":"Focal segmental glomerulosclerosis in African Americans","volume":"323","author":"Tucker","year":"2002","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.xkme.2024.100831_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086678","article-title":"The reasons for geographic and racial differences in stroke study: objectives and design","volume":"25","author":"Howard","year":"2005","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.xkme.2024.100831_bib18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1523-1755.2005.00553.x","article-title":"Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline results","volume":"68","author":"Warnock","year":"2005","journal-title":"Kidney Int"},{"issue":"16-17","key":"10.1016\/j.xkme.2024.100831_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clinbiochem.2014.08.003","article-title":"Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort","volume":"47","author":"Gillett","year":"2014","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.xkme.2024.100831_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.ajkd.2015.05.023","article-title":"Waist circumference, body mass index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study","volume":"67","author":"Kramer","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2024.100831_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annepidem.2021.10.010","article-title":"Biomarkers as MEDiators of racial disparities in risk factors (BioMedioR): rationale, study design, and statistical considerations","volume":"66","author":"Long","year":"2022","journal-title":"Ann Epidemiol"},{"issue":"20","key":"10.1016\/j.xkme.2024.100831_bib22","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.xkme.2024.100831_bib23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.xkme.2024.100831_bib24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/aje\/kwp151","article-title":"Defining incident chronic kidney disease in the research setting: the ARIC study","volume":"170","author":"Bash","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.xkme.2024.100831_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease","volume":"12","author":"Thomas","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2024.100831_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11886-021-01546-8","article-title":"Intersection between chronic kidney disease and cardiovascular disease","volume":"23","author":"Laffin","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"10.1016\/j.xkme.2024.100831_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semnephrol.2021.03.013","article-title":"Obesity, chronic kidney disease, and kidney transplantation: an evolving relationship","volume":"41","author":"Azhar","year":"2021","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2024.100831_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.amjcard.2018.03.009","article-title":"Usefulness of proneurotensin to predict cardiovascular and all-cause mortality in a United States population (from the Reasons for Geographic and Racial Differences in Stroke study)","volume":"122","author":"Wettersten","year":"2018","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.xkme.2024.100831_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-20-0087","article-title":"Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease","volume":"183","author":"T\u00f6njes","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.xkme.2024.100831_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3892\/etm.2021.9969","article-title":"Impact of adipose tissue in chronic kidney disease development (review)","volume":"21","author":"Miricescu","year":"2021","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.xkme.2024.100831_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semnephrol.2012.12.002","article-title":"The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases","volume":"33","author":"R\u00fcster","year":"2013","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2024.100831_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12882-022-02795-7","article-title":"Serum leptin level and incidence of CKD: a longitudinal study of adult enrolled in the Korean genome and epidemiology study(KoGES)","volume":"23","author":"Park","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.xkme.2024.100831_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biochi.2014.06.024","article-title":"Leptin as an uremic toxin: deleterious role of leptin in chronic kidney disease","volume":"105","author":"Alix","year":"2014","journal-title":"Biochimie"},{"issue":"3 suppl 1","key":"10.1016\/j.xkme.2024.100831_bib34","first-page":"S1","article-title":"US Renal Data System 2015 annual data report: epidemiology of kidney disease in the United States","volume":"67","author":"Saran","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2024.100831_bib35","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","article-title":"Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States","volume":"14","author":"Hsu","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"year":"2016","series-title":"Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities","key":"10.1016\/j.xkme.2024.100831_bib36"},{"issue":"5","key":"10.1016\/j.xkme.2024.100831_bib37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.ajkd.2006.07.023","article-title":"Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD","volume":"48","author":"Bryson","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"10010","key":"10.1016\/j.xkme.2024.100831_bib38","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Forouzanfar","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.xkme.2024.100831_bib39","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/01.ASN.0000026493.18542.6A","article-title":"Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors","volume":"13","author":"Tarver-Carr","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2024.100831_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/2013.jamainternmed.857","article-title":"Racial differences in the impact of elevated systolic blood pressure on stroke risk","volume":"173","author":"Howard","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.xkme.2024.100831_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/aje\/kwy253","article-title":"An investigation of selection bias in estimating racial disparity in stroke risk factors","volume":"188","author":"Long","year":"2019","journal-title":"Am J Epidemiol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059524000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059524000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T16:59:21Z","timestamp":1717865961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059524000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2590059524000426"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2024.100831","relation":{},"ISSN":["2590-0595"],"issn-type":[{"type":"print","value":"2590-0595"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proneurotensin\/Neuromedin N and Risk of Incident CKD and Other Kidney Outcomes in Community-Living Individuals: The REGARDS Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2024.100831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}],"article-number":"100831"}}